Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio
Investing your money in health or medical companies is difficult. The complexity of the science often deters investors from allocating a portion of their portfolio
Nevro (NVRO.NYSE) announced their intentions to establish global manufacturing operations in Costa Rica to both invest in and support the company’s growth trajectory and expectations.
There’s a million ways to invest, and we’ve covered most of them. You could follow Warren Buffett’s market moves, commit to a specific pattern and
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early pre-symptomatic and asymptomatic stages of infection
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”
Institutional failure at every level of decision making in the United States is why COVID-19 in the world’s largest economy is neither contained nor controlled.
The new economy is digital. It’s in the trillions, so increasing digitization of the world has led to an increased risk that some parts of
Given the grim human and financial data, it’s no surprise that biotech companies and their shareholders are focussed on developing coronavirus solutions.
Doing what we do at Equity Guru, every day, we receive emails and dms from shareholders of different companies – all expressing their grievances. Disgruntled
Willow Biosciences (WLLW.T) is a Canadian biotech company based in Vancouver, BC, that is using “a proprietary yeast strain laboratory process” to produce commercial quantities of CBD and CBG”.
Over twenty million people worldwide have contracted COVID-19. Of those 12.4 million have recovered and approximately 738,000 have died at the time of writing, according
Revive has a partnership agreement with the Reed Research Group out of the University of Wisconsin-Madison to evaluate novel formulations of psilocybin.
Red Light Holland (TRIP.C) has fast-tracked its 3,000 square-foot custom-built indoor production and distribution facility in Horst, the Netherlands, and is now growing its first
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
Mydecine Innovations Group’s (MYCO.C) subsidiary Mindleap Health expanded its digital therapeutic services, dealing specifically with addiction, by adding three new programs to its platform. This
Bio-Techne (TECH.Q), together with Kantaro Biosciences, a commercial affiliate of Mount Sinai Health, announced today the expected release of their COVID-SeroIndex antibody kit. The SeroIndex
CytoSorbents (CTSO.Q) has been awarded a three-year contract valued at $4,421,487 to complete a preclinical development of the HemoDefend plasma and whole blood adsorber by
Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy.
Formerly dismissed-by-many pharmaceutical company Revive Therapeutics (RVV.C) jumped a whopping 68% Friday upon revealing it has been granted approval to move forward with phase 3
For the last eight months, the Covid-19 virus has been the centre of attention in the media, the markets, and the medical field. Collectively, countries,
Ovation Science’s (OVAT.C) DermSafe hand sanitizer lotion has gotten the Dermatological Review Panel’s (DRP) final seal of approval. The DRP is a group of Canadian
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should
Cognizant’s (CTSH.Q) shared investigator platform (SIP) has reached over 100,00 new users in 84 countries, according to a press release. The software as a service
We have a healthcare problem in this country. The number of physicians in Canada grew by 12.5% between 2014 and 2018, while the population grew
War is a part of human nature. It’s the greatest driver of human innovation, and if we’re inclined to be cynical we could state that
Edwards Lifesciences Corporation (EW.NYSE) received U.S. Food and Drug Administration (FDA) approval for the KONECT RESILIA aortic valved conduit (AVC) today. The AVC is the
Aytu BioScience (AYTU.Q) signed a distribution agreement with Apollo Med Innovations to distribute their COVID-19 IgG/IgM Rapid Test Cassette to Apollo’s network of 1,000 doctor’s
Biotech companies especially those tackling Covid-19 are seeing incredible bumps on the boards with companies like Canadian Sona Nanotech (SONA.C), based out of Halifax, Nova
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to do the due diligence for biotechs because it’s “too hard”.
An independent study has determined that Ovation Science’s (OVAT.C) Dermsafe hand sanitizer lotion is effective against one of the various human coronaviruses, the beta coronavirus
Cancer focused biopharmaceutical company, Unum Therapeutics (UMRX.Q) completed their acquisition of biotech company Kiq LLC today. Kiq works on the discovery and development of kinase
For part I of this series please click here. Cities across Canada are gradually returning to business as usual, and we’re winning the fight against
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto.
The history of humanity is the history of disease. We’ve mostly bumbled around from plague to plague, blind-sided and punch drunk by the ferocity of
The ongoing COVID-19 drama that’s dragged markets to its knees may almost be over, as finally companies have made some headway and there’s a drug
3a-Diagnostics, a diagnostic partner for Xphyto Therapeutics (XPHY.C), confirmed the functionality of the peptide biosensors working in Xphyto’s oral dissolvable thin film (ODF) platform today.
One of Roadman Investments (LITT.V) subsidiaries, CLOV Biopharma, recently completed its research program at UBC on cedar leaf oil vapour, but the Securities Exchange Commission
Keynes once said that “the market can remain irrational longer than you can remain solvent”. Fundamentals departed market valuation long ago, but you could’ve at least expected market reaction to be in response to COVID-19 related news. Except it seems like that’s no longer the case.
The scientific process isn’t exactly what you were taught in grade 4. There’s a lot more to it, owing to some historical—well, let’s call them
Puration (PURA.OTC) will acquire a CBD sexual wellness product line, the company announced today in a press release. Pura’s revenue comes mostly through the sales
Internet of Things (ITT.V) launched a presales program for ThermalPass, their artificial-intelligence-enabled thermal sensor, temperature screening system today. On June 17, 2020, Dr. Anthony Fauci,
Liberty Leaf Holdings (LIB.C) made a right-turn into psychedelics with their latest acquisition of Nova Mentis Biotech today. Now that mushrooms have started gathering serious
This week’s digest of mushroom moves is a mixed bag of trash and glory, with the shrooms sector increasingly looking like the early days of the cannabis rush.
Small caps in Canada, especially in tech, are full of faux-companies. You know, the kind where the problem being solved isn’t really a problem, and
CloudMD Software and Services (DOC.V) signed a binding term sheet to acquire 51% of mixed telemedicine and family and specialist medical clinic, West Mississauga Medical
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly.
Mydecine Innovations Group (MYCO.C) signed a non-binding letter of intent to acquire NeuroPharm, a Canadian-based healthcare company involved in the nascent shroom-space earlier this week.
Numinus Wellness (NUMI.V) is the first company to receive the Health Canada nod to standardize the extraction of psilocybin from mushrooms. The Health Canada nod
Predictmedix and MobileWellbeing are attacking the Telehealth problem from different angles.
BrainStorm Cell Therapeutics (BCLI.Q), a biotech company involved in a research study for amyotrophic lateral sclerosis (ALS), received a combined $500,000 grant from The ALS
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies.
Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three reasons you think it’s great, and one thing you’ll openly admit they need to do better.” I got 35. Gulp.
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days,
Scientists don’t have all the answers—if they did they would be out of a job—and sometimes that answer isn’t good enough. Especially for people who
Nutritional High International (EAT.C) signed an LOI to acquire Kruzo LLC, a company involved in development and research of products surrounding the psychoactive cacti peyote,
Over the last couple of months, companies have found a way to muster up an effort to align their objectives with helping society recover from
Cognetivity Neurosciences’ (CGN.C) latest scientific publication touts their Integrated Cognitive Assessment (ICA) tool as a weapon for detecting and monitoring cognitive impairment associated with neurodegenerative
Inovio Pharmaceuticals (INO.Q) announced the publication of the preclinical study data for its COVID-19 DNA vaccine, IN0-4800, demonstrating neutralizing antibody and T-cell immune responses against
“Predictmedix’ best-in-class screening technology pairs perfectly with our ability to custom-fabricate quickly and efficiently,” states Jonathan Auger, CEO of Juiceworks Exhibits
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in
Naturally Splendid (NSP.T) signed an LOI with Vancouver-based Biological Pharmamedical Research to form a joint venture to continue developing and pursuing phase two clinical studies,
Champignon Brands (SHRM.C) recent term sheet with California-based Wellness Clinic of Orange County not only furthers the company’s North American clinical expansion, but gives them
Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19)
Two weeks ago, Predictmedix filed a Patent Application in the U.S. for its AI-driven rapid screening system for infectious diseases.
We’re two months in on this pandemic and governments are thinking about reopening the economy for the summer when the traditional flu season winds down.
It’s ironic that May has been deemed mental health month. Outside my balcony door the sun is sets below a gradually dimming horizon while a
Growing old is a messy business.
Institutional care for seniors will never provide perfect solutions.
The challenge is not to make a perfect system, but to mitigate the health risks of long term care, intelligently and ethically.
Abbott Laboratories (ABT.NYSE) announced their FreeStyle Libre system, a sensor-based glucose monitoring tech, is now being used in hospitals setting during the COVID-19 pandemic. This
We’ve all seen it: the media craze about gluten and how it’s terrible for us. Except it generally lacks solid scientific consensus, and like most
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he
Mind Medicine (MMED.E) has worked together with University Hospital Basel’s Liechti Laboratory to discover and file and patent application in the United States for a
Neptune Wellness Solutions (NEPT.T) reported today that their phase II expansion at their Sherbrooke, Quebec, facility is online and has received approvals to run product
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts from certain folks wondering if that meant trouble for us – or them. It’s not a problem for us; our coverage has been appropriately even-handed.
Sona Nanotech (SONA.C) entered into service and supply agreements with a European-based contract organization to manufacture its COVID-19 rapid response virus detection test yesterday. The
CloudMD Software and Services (DOC.C) has expanded the reach of its telemedicine app, CloudMD, to service Ontarians. Even before the coronavirus made going outside for
Revive Therapeutics (RVV.C) intends to advance its product pipeline to human clinical studies in regions where its products have already acquired regulatory approval and are
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S. and 1 billion worldwide.”
Mind Medicine (MMED.E) started enrolling candidates for further human safety trial studies of 18-MC, the company’s orally taken ibogaine derivative for the treatment of opioid
Trust me, there’s nothing I’d like more, as the publisher of a financial markets-focused media outlet, than to tell you all it’s time to buy
Being working class in the United States in the time of Donald Trump is a curious endeavour. The stories coming from some of my friends
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
Tragedy and trying times brings out both the best and the worst in humanity. We have doctors and nurses risking their health and safety everyday
Last week, NMC admitted that it identified an additional $2.7 billion in debt, rounding the total debt to around $5 billion. NMC staff were not paid last month.
Regardless of how you might feel about it, the point remains: the flipside of any disaster is opportunity for those who know how and where
When a sector gets hot, small cap stocks can often get a bump by sidling up to the hot sector with a new product/idea/opportunity. When the dust clears, the intrinsic value of the new offering is typically deemed to be low. We saw it in 3D-printing, with Dung Beetle Treats. We saw it in weed with a $1 billion website that forgot to sell cannabis. We saw it in blockchain with a Cryptocoin for porno transactions.
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on board. Champignon Brands (SHRM.C) zoomed 40% to $0.33 on a lot smaller market awareness spend byt a handy ticker, Roadman Investments (LITT.V) was up 30% to $0.065 being sucked along in the other two companies’ wake, and Revive Therapeutics (RVV.C) was up 81% to $0.10 on ripples caused by the rest.
As happens whenever a global crisis hits, there are plenty of investors currently watching the global Coronavirus outbreak and looking to panic sell. There are also a few looking to capitalize on the opportunities found in potential doom. Like folks who buy gun stocks whenever a military conflict breaks out, or those who buy gold as a safe haven when the world’s leaders engage in a game of ‘Armageddon chicken.’ a pandemic brings about macroeconomic changes that can be utilised to make money.
We’ll take a wild guess that precisely NONE of the retail investors who just drove up the price of the MRNA would recognise a “stabilized form of S protein” if they met it on a beach, made sand castles with it – then took it home to play Spin-The-Bottle.
Roadman Investments’ (LITT.V) recent acquisition target CLOV Biopharma (CBP) is continuing its research into the potential commercial uses of cedar leaf oil vapour (CLOV), specifically
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they know how to turn out the playahs, and the only way you keep big money showing up is to be a little bit picky with what you offer them. Don’t waste anyone’s time and they’ll know it’s cool to return.
Soligenix (SNGX.Q), a biopharma company that develops and commercializes products for rare diseases, announced that its RiVax, which is a heat stable ricin toxin vaccine,
“A once-a-day pill that reduces HbA1c and improves time in range with continuous glucose monitoring, without increasing hypoglycemia or any signal for adverse events, is a big win for the future care of type 1 diabetes,” stated clinical researcher Dr. John Buse.
If you’ve had your eye off the biotech sector recently because it doesn’t directly involve gold or cannabis, you’re missing out on one of the
A Harvard University Study calculates the economic burden from diabetes at about $1.3 trillion, or 1.8% of global GDP.
Pregnancy is one of those things television makes look easy. Boy and girl both swipe appropriately on Tinder. They meet in a musty stairwell after
Xphyto (XPHY.C) is dominating the cannabis sector like Sean Kemp used to dominate the Seattle buffet scene. It’s a legit beast right now, jumping from
A Wuhan market price list offers 112 types of wild critters including peacocks, foxes, giant salamanders, snakes, rats, porcupines and camel meat.